267 related articles for article (PubMed ID: 24778133)
1. Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL.
Aspord C; Leccia MT; Charles J; Plumas J
Cancer Immunol Res; 2013 Dec; 1(6):402-15. PubMed ID: 24778133
[TBL] [Abstract][Full Text] [Related]
2. Melanoma hijacks plasmacytoid dendritic cells to promote its own progression.
Aspord C; Leccia MT; Charles J; Plumas J
Oncoimmunology; 2014 Jan; 3(1):e27402. PubMed ID: 24701375
[TBL] [Abstract][Full Text] [Related]
3. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
[TBL] [Abstract][Full Text] [Related]
4. Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs.
Ito T; Amakawa R; Inaba M; Hori T; Ota M; Nakamura K; Takebayashi M; Miyaji M; Yoshimura T; Inaba K; Fukuhara S
J Immunol; 2004 Apr; 172(7):4253-9. PubMed ID: 15034038
[TBL] [Abstract][Full Text] [Related]
5. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas.
Vermi W; Bonecchi R; Facchetti F; Bianchi D; Sozzani S; Festa S; Berenzi A; Cella M; Colonna M
J Pathol; 2003 Jun; 200(2):255-68. PubMed ID: 12754747
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.
McCarter MD; Baumgartner J; Escobar GA; Richter D; Lewis K; Robinson W; Wilson C; Palmer BE; Gonzalez R
Ann Surg Oncol; 2007 Oct; 14(10):2854-60. PubMed ID: 17593331
[TBL] [Abstract][Full Text] [Related]
7. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.
Faget J; Bendriss-Vermare N; Gobert M; Durand I; Olive D; Biota C; Bachelot T; Treilleux I; Goddard-Leon S; Lavergne E; Chabaud S; Blay JY; Caux C; Ménétrier-Caux C
Cancer Res; 2012 Dec; 72(23):6130-41. PubMed ID: 23026134
[TBL] [Abstract][Full Text] [Related]
8. OX40 ligand regulates splenic CD8⁻ dendritic cell-induced Th2 responses in vivo.
Kamachi F; Harada N; Usui Y; Sakanishi T; Ishii N; Okumura K; Miyake S; Akiba H
Biochem Biophys Res Commun; 2014 Feb; 444(2):235-40. PubMed ID: 24462862
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated NF-κB-Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma.
Maurer DM; Adamik J; Santos PM; Shi J; Shurin MR; Kirkwood JM; Storkus WJ; Butterfield LH
Cancer Immunol Res; 2020 Dec; 8(12):1554-1567. PubMed ID: 33051240
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cells, a role in neoplastic prevention and progression.
Lombardi VC; Khaiboullina SF; Rizvanov AA
Eur J Clin Invest; 2015 Jan; 45 Suppl 1():1-8. PubMed ID: 25524580
[TBL] [Abstract][Full Text] [Related]
11. Collapse of the Plasmacytoid Dendritic Cell Compartment in Advanced Cutaneous Melanomas by Components of the Tumor Cell Secretome.
Vescovi R; Monti M; Moratto D; Paolini L; Consoli F; Benerini L; Melocchi L; Calza S; Chiudinelli M; Rossi G; Bugatti M; Maio M; Fonsatti E; Farisoglio C; Simbolo M; Almici C; Verardi R; Scarpa A; Bergese P; Manganoni A; Facchetti F; Vermi W
Cancer Immunol Res; 2019 Jan; 7(1):12-28. PubMed ID: 30401679
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer.
Kießler M; Plesca I; Sommer U; Wehner R; Wilczkowski F; Müller L; Tunger A; Lai X; Rentsch A; Peuker K; Zeissig S; Seifert AM; Seifert L; Weitz J; Bachmann M; Bornhäuser M; Aust D; Baretton G; Schmitz M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762320
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway.
Godefroy E; Manches O; Dréno B; Hochman T; Rolnitzky L; Labarrière N; Guilloux Y; Goldberg J; Jotereau F; Bhardwaj N
Cancer Cell; 2011 Mar; 19(3):333-46. PubMed ID: 21397857
[TBL] [Abstract][Full Text] [Related]
14. Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node.
Gai XD; Song Y; Li C; Lei YM; Yang B
Pathol Res Pract; 2013 Dec; 209(12):774-8. PubMed ID: 24080284
[TBL] [Abstract][Full Text] [Related]
15. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid dendritic cells have a cytokine-producing capacity to enhance ICOS ligand-mediated IL-10 production during T-cell priming.
Ogata M; Ito T; Shimamoto K; Nakanishi T; Satsutani N; Miyamoto R; Nomura S
Int Immunol; 2013 Mar; 25(3):171-82. PubMed ID: 23125331
[TBL] [Abstract][Full Text] [Related]
17. The avidity of tumor-specific T cells amplified by a plasmacytoid dendritic cell-based assay can predict the clinical evolution of melanoma patients.
Charles J; Chaperot L; Revol B; Baudin M; Mouret S; Hamon A; Leccia MT; Plumas J; Aspord C
Pigment Cell Melanoma Res; 2018 Jan; 31(1):82-94. PubMed ID: 28741900
[TBL] [Abstract][Full Text] [Related]
18. Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3.
Camisaschi C; De Filippo A; Beretta V; Vergani B; Villa A; Vergani E; Santinami M; Cabras AD; Arienti F; Triebel F; Rodolfo M; Rivoltini L; Castelli C
J Invest Dermatol; 2014 Jul; 134(7):1893-1902. PubMed ID: 24441096
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid dendritic cells contribute to doxorubicin-induced tumor arrest in a mouse model of pulmonary metastasis.
Terlizzi M; Popolo A; Pinto A; Sorrentino R
J Immunother; 2014 May; 37(4):214-24. PubMed ID: 24714355
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand.
Ito T; Yang M; Wang YH; Lande R; Gregorio J; Perng OA; Qin XF; Liu YJ; Gilliet M
J Exp Med; 2007 Jan; 204(1):105-15. PubMed ID: 17200410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
